Skin Clearance, Treatment Response Off-therapy, and Safety of Tapinarof Cream 1% Once Daily: Results from ADORING 3, a 48-week Phase 3 Trial in Adults and Children Down to 2 Years of Age with Atopic Dermatitis. J of Skin [Internet]. 2024 Nov. 18 [cited 2025 Jun. 13];8(6):s460. Available from: https://skin.dermsquared.com/skin/article/view/3111